| Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442) |
|---|
| 11/11/2009 | CN101575322A Alkyl ketene, preparation method and application thereof |
| 11/10/2009 | US7615653 Anti-tuberculosis taxane compounds |
| 11/05/2009 | US20090275762 Anhydrous crystalline form of docetaxel; more stable than trihydrated form; chemical stability |
| 11/05/2009 | US20090275756 2-oxetanone derivative and process for production thereof |
| 11/03/2009 | CA2356896C Method for high yield extraction of paclitaxel from paclitaxel-containing material |
| 10/28/2009 | EP2111397A2 Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins |
| 10/28/2009 | CN100554258C Semi-synthesis process of taxol and docetaxel |
| 10/27/2009 | US7608632 Sulfonamide inhibitors of aspartyl protease |
| 10/21/2009 | CN101563333A Method of preparing taxane derivatives and intermediates used therein |
| 10/21/2009 | CN101560197A Extraction method of taxol from branches and leaves of artificially cultivated yew |
| 10/20/2009 | US7605279 Process for producing alicyclic oxetane compound |
| 10/20/2009 | US7605278 Methods and compositions for converting taxane amides to paclitaxel or other taxanes |
| 10/20/2009 | CA2397591C Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
| 10/20/2009 | CA2368993C C7 ester substituted taxanes as antitumor agents |
| 10/14/2009 | EP2108014A1 Method of preparing docetaxel and intermediates used therein |
| 10/14/2009 | CN101558051A Method of preparing docetaxel and intermediates used therein |
| 10/13/2009 | US7601853 Lactone stabilizing compositions |
| 10/13/2009 | CA2472373C Combination of paclitaxel and a polymer |
| 10/13/2009 | CA2368274C C10 ester substituted taxanes as antitumor agents |
| 10/07/2009 | CN100546986C Methods for obtaining paclitaxel from taxus plants |
| 10/06/2009 | US7598290 Cytotoxic agents comprising new C-2 modified taxanes |
| 10/01/2009 | WO2009118743A1 Improved fermentation process for higher yield coefficient of lipase-inhibitor with respect to consumed fatty acid |
| 10/01/2009 | CA2719581A1 Improved fermentation process for higher yield coefficient of lipase-inhibitor with respect to consumed fatty acid |
| 09/30/2009 | CN101544622A Method for semi-synthesizing taxol via 9-dihydro-13-acetyl baccatin III |
| 09/30/2009 | CN100545155C Synthesis process of taxol and docetaxel with new side chain and their derivatives |
| 09/24/2009 | WO2009115655A2 Crystalline forms of dimethoxy docetaxel and methods for preparing same |
| 09/24/2009 | WO2009068682A3 Phenyl-oxetanyl-derivatives |
| 09/24/2009 | WO2009053482A3 Activated methylene reagents and curable compositions prepared therefrom |
| 09/24/2009 | CA2712373A1 Crystalline forms of dimethoxy docetaxel and methods for preparing same |
| 09/23/2009 | EP2101577A1 Oxooxetane as a fungicidal agent |
| 09/23/2009 | CN100543020C Method for extracting pacilitaxel from artificial planted south yew of whole plant |
| 09/22/2009 | US7592414 Materials that can be structured, method for producing the same and their use |
| 09/17/2009 | US20090232833 Polyalkylene oxides having hindered ester-based biodegradable linkers |
| 09/16/2009 | CN101531645A Synthesis method of Duoxitasai |
| 09/16/2009 | CN100540544C Semi-synthesis of taxane intermediates and aziridine analogues and their conversion to paclitaxel and docetaxel |
| 09/15/2009 | US7589239 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 09/15/2009 | US7589111 Antitumor agents; improved efficacy and less toxicity; taxane having a cyclopentyl ester substituent at C10, a keto substituent at C9, a hydroxy substituent at C2, a 2-thienyl substituent at C3' and an isopropoxycarbamate substituent at C3'. |
| 09/09/2009 | EP1673359B1 Process for the preparation of crystalline forms of orlistat |
| 09/09/2009 | CN101528720A Semi-synthetic route for the preparation of paclitaxel, docetaxel and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III |
| 09/09/2009 | CN101525321A Polyenic taxusol sesquihydrate crystal and preparation method thereof |
| 09/09/2009 | CN100537555C Method for high efficiency separating and purifying 1-deacetyl Baccatins III (10-DABIII) |
| 09/09/2009 | CN100537554C Docetaxel crystal system and preparation method thereof |
| 09/08/2009 | US7585986 Semi-synthesis of taxane intermediates and aziridine analogues and their conversion to paclitaxel and docetaxel |
| 09/08/2009 | US7585857 Cytotoxic agents comprising taxanes and their therapeutic use |
| 09/03/2009 | US20090221786 Taxol immunoassay |
| 09/02/2009 | EP2094084A2 Process for making crystalline anhydrous docetaxel |
| 09/01/2009 | USRE40901 14- Beta -hydroxy-1,14-carbonate-baccatine III and V derivatives, 13-substituted by an isoserine residue; remarkable cytotoxic and anticarcinogenic-agent activities; capable of overcoming the resistance of cell lines expressing the multidrug resistant phenotype; breast, ovarian, colon cancers |
| 08/27/2009 | WO2008026048A3 Stable injectable pharmaceutical compositions of docetaxel |
| 08/27/2009 | US20090216031 Process for the isolation of paclitaxel |
| 08/27/2009 | US20090215883 Pharmaceutical formulation comprising taxane, a solid composition of taxane, a process for preparing said solid composition of taxane, a solubilizing composition of said solid composition of taxane, and a kit for the injectable formulation of taxane |
| 08/26/2009 | EP2091932A1 Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes |
| 08/26/2009 | EP2091931A2 A process for the preparation of secotaxanes |
| 08/25/2009 | US7579491 Process for preparing brevifoliol |
| 08/18/2009 | CA2219675C Pentacyclic compound |
| 08/12/2009 | EP2086953A1 Polymerizable liquid crystal compound, phase difference film and liquid crystal display using the same |
| 08/12/2009 | CN101503396A Semisynthesis of paclitaxel |
| 08/06/2009 | WO2009095522A1 Taxanes, precursors thereof and method for obtaining same |
| 08/05/2009 | CN100522955C Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 08/05/2009 | CN100522249C Elogated and multiple spacers in activatible prodrugs |
| 08/04/2009 | US7569709 Low pressure carbonylation of heterocycles |
| 07/29/2009 | EP1461315B1 Catalytic carbonylation of three and four membered heterocycles |
| 07/29/2009 | CN101492432A Paclitaxel produced by separation purification of epiphyte with high-efficiency solid phase abstraction-HPLC method |
| 07/22/2009 | CN101490026A 2-oxetanone derivative and process for production thereof |
| 07/22/2009 | CN101486692A Preparation of optically pure (R)-4-trihalomethyl-2-heterocycle butanone |
| 07/21/2009 | US7563914 Method for preparing paclitaxel |
| 07/08/2009 | EP2077264A2 Taxane derivatives and a process for the preparation thereof |
| 07/08/2009 | CN101479251A Method for the production of oxetane group-containing (meth)acrylates |
| 07/07/2009 | USRE40839 Taxol treatment of cancer |
| 07/02/2009 | US20090171104 Process for the preparation of orlistat |
| 07/02/2009 | US20090169985 Electrolytic solution, secondary battery and method of manufacturing same, and sulfone compound |
| 07/01/2009 | CN101468974A Semi-synthesizing method for polyenic taxusol |
| 06/23/2009 | US7550609 Biological conjugates for tumor targeted treatment; novel taxanes having mercapto or disulfide groups; side effect reduction without compromising their cytotoxicity |
| 06/23/2009 | US7550608 Processes for the preparation of docetaxel |
| 06/18/2009 | WO2009074321A1 Rapid activation of surfactant precursor |
| 06/18/2009 | US20090156828 Novel Compounds and Methods for Forming Taxanes and Using the Same |
| 06/18/2009 | US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 06/17/2009 | CN101460473A Thermal extraction method and product |
| 06/16/2009 | CA2258066C Isolation and purification of paclitaxel, and other related taxanes by industrial preparative low pressure chromatography on a polymeric resin column |
| 06/11/2009 | US20090149665 Fluorine-containing adamantane derivative, fluorine-containing adamantane derivative having polymerizable group, and resin composition containing same |
| 06/10/2009 | CN101454303A 3-ethyloxethane compound having hydroxyl group and method for producing the same |
| 06/10/2009 | CN100497453C Low acidity phosphate esters |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497327C Use of polymerization type chiral catalyst in kinetic resolution of epoxy compound |
| 06/04/2009 | WO2009069668A1 Agent for increasing the expression of malignant melanoma antigen, and use thereof |
| 06/04/2009 | WO2009068682A2 Phenyl-oxetanyl-derivatives |
| 06/04/2009 | CA2707095A1 Phenyl-oxetanyl-derivatives |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP1165553B1 C10 ester substituted taxanes as antitumor agents |
| 06/02/2009 | US7541454 Compounds and methods for fluorescent labeling |
| 06/02/2009 | CA2402519C Process for manufacturing paclitaxel and 13-acetyl-9-dihydrobaccatin iii |
| 05/28/2009 | US20090137796 Methods for the preparation of taxanes using chiral auxiliaries |
| 05/28/2009 | US20090137775 Adamantane derivative, epoxy resin, and optical electronic member using resin composition comprising them |
| 05/28/2009 | US20090137774 Adamantane derivative, resin composition containing same, and optoelectronic component using same |
| 05/27/2009 | CN101440056A Method for splitting docetaxel side chain intermediate |
| 05/27/2009 | CN100491363C C7 ester-substituted taxane |
| 05/26/2009 | CA2445478C Retinol derivatives potentiation of active substances by micellar preparation |
| 05/22/2009 | WO2009062342A1 Cephalomannine derivatives and their preparation, medicinal composition and use |
| 05/22/2009 | CA2705481A1 Cephalomannine derivatives, their preparation, pharmaceutical composition and use thereof |
| 05/21/2009 | US20090130163 Drugs With Improved Hydrophobicity For Incorporation in Medical Devices |